1. Home
  2. MRVI vs INVZ Comparison

MRVI vs INVZ Comparison

Compare MRVI & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • INVZ
  • Stock Information
  • Founded
  • MRVI 2014
  • INVZ 2016
  • Country
  • MRVI United States
  • INVZ Israel
  • Employees
  • MRVI N/A
  • INVZ N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • INVZ Auto Parts:O.E.M.
  • Sector
  • MRVI Health Care
  • INVZ Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • INVZ Nasdaq
  • Market Cap
  • MRVI 376.2M
  • INVZ 369.4M
  • IPO Year
  • MRVI 2020
  • INVZ N/A
  • Fundamental
  • Price
  • MRVI $3.34
  • INVZ $2.37
  • Analyst Decision
  • MRVI Hold
  • INVZ Strong Buy
  • Analyst Count
  • MRVI 9
  • INVZ 4
  • Target Price
  • MRVI $4.54
  • INVZ $3.27
  • AVG Volume (30 Days)
  • MRVI 1.4M
  • INVZ 9.7M
  • Earning Date
  • MRVI 11-06-2025
  • INVZ 11-12-2025
  • Dividend Yield
  • MRVI N/A
  • INVZ N/A
  • EPS Growth
  • MRVI N/A
  • INVZ N/A
  • EPS
  • MRVI N/A
  • INVZ N/A
  • Revenue
  • MRVI $219,830,000.00
  • INVZ $37,684,000.00
  • Revenue This Year
  • MRVI N/A
  • INVZ $153.22
  • Revenue Next Year
  • MRVI $7.23
  • INVZ $91.44
  • P/E Ratio
  • MRVI N/A
  • INVZ N/A
  • Revenue Growth
  • MRVI N/A
  • INVZ 17.32
  • 52 Week Low
  • MRVI $1.67
  • INVZ $0.45
  • 52 Week High
  • MRVI $8.54
  • INVZ $3.14
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 69.44
  • INVZ 69.30
  • Support Level
  • MRVI $2.94
  • INVZ $1.66
  • Resistance Level
  • MRVI $3.30
  • INVZ $2.48
  • Average True Range (ATR)
  • MRVI 0.20
  • INVZ 0.18
  • MACD
  • MRVI 0.04
  • INVZ 0.05
  • Stochastic Oscillator
  • MRVI 91.98
  • INVZ 88.68

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

Share on Social Networks: